Get the latest Science News and Discoveries
Lundquist investigator Dr. Ashraf Ibrahim is the lead author in the landmark study on pioneering oral fungal infection ... - EurekAlert
A novel oral amphotericin B (MAT2203) developed by Matinas BioPharma for treatment of invasive mucormycosis (IM) and other deadly invasive fungal infections, has demonstrated encouraging results in a series of preclinical studies. The groundbreaking research, led by Lundquist Institute (TLI) Investigator Ashraf Ibrahim, PhD, has been published in the journal <em>Antimicrobial Agents and Chemotherapy</em>.
None
Or read this on Eureka Alert